J amp;J May End Stent Shortcomings With Guidant Buy Credit Suisse First Boston maintained  quot;neutral quot; ratings on Guidant (nyse: GDT - news - people ) and Johnson  amp; Johnson (nyse: JNJ - news - people ), saying a near-term acquisition of the former by the latter values Guidant at \$76.